Redalpine is one of the leading European Venture Capital investors with a focus on highly scalable start-ups. The firm's mission is to help talented entrepreneurs turn an ambitious vision into reality by providing money, experience, coaching, and a strong network. The firm is focused on seed and early-stage investments in disruptive technologies in tech and health tech. Redalpine launched its first fund (Redalpine Capital I) in 2007, following the founding partners’ track record of some excellent trade sales and IPOs as serial entrepreneurs and professional angel investors. In 2021 Redalpine closed its sixth fund (Redalpine Capital VI) and currently has approx. USD 1 Billion in AUM. The highly interdisciplinary Redalpine team supports more than 70 portfolio companies with operational and sector-specific expertise and with a rich international network.

25

ca. CHF 1bn

Redalpine Capital I, Redalpine Capital II, Redalpine Capital III, Redalpine Capital IV, Redalpine Capital VI, Redalpine Opportunity Fund

76

Taxfix, N26, Lunaphore, ZenJob, Home, Carvolution, Araris, Lengoo, ImmunOs, Donut, Daedalean, Portify Vivere, Versantis, Inkitt, Eracal, Enway, Bnext, Aktiia, Morressier, LemonOne, Tolremo, Memo Therapeutics, Razor, felmo

2007

Independent Private Partnership

Early-Stage, Seed Capital, Start-up Capital

Computer Related, Finance - Insurance - Real Estate, Internet Technology, Medical - Life Sciences - Health Related, Communications other

Europe

Equity Financing

-

CHF 1-8m

-

CHF 0.2m

CHF 8m